The FDA unveils a fast-track review voucher for national health priorities. This and more in this week’s life sciences update. … READ MORE >
biotech
5 things to know in life sciences: Week of May 26, 2025
China overtakes U.S. in global drug trials. This and more in this week’s life sciences update. … READ MORE >
5 things to know in life sciences: Week of May 5, 2025
Patent reform sparks divide between pharma and tech. This and more in this week’s life sciences update. … READ MORE >
5 things to know in life sciences: Week of April 28, 2025
Each week we highlight five things affecting the life sciences industry. Here’s the latest. … READ MORE >
5 things to know in life sciences: Week of April 7, 2025
Each week we highlight five things affecting the life sciences industry. Here’s the latest. … READ MORE >
Biopharma IPO outlook: A shift amid uncertainty?
While the biopharma IPO market has been sluggish, there may be a shift in the marketplace later this year, particularly for later-stage biopharma companies. … READ MORE >
5 things to know in life sciences: Week of March 24, 2025
Pharma companies collaborate on secure data sharing for AI. This and more in this week’s update. … READ MORE >
5 things to know in life sciences: Week of March 3, 2025
The importance of data governance in pharma’s AI integration. This and more in this week’s life sciences update. … READ MORE >
5 things to know in life sciences: Week of Feb. 10, 2025
Large pharmaceutical companies are turning to AI more frequently, despite some challenges. This and more in this week’s update. … READ MORE >
5 things to know in life sciences: Week of November 18, 2024
Each week we highlight five things affecting the life sciences industry. Here’s the latest. CAR-T therapy for lupus gains attention CAR-T cell therapy shows significant potential in treating lupus—as discussed at ACR 2024–with early trials indicating improved patient outcomes and reduced disease activity, reports BioSpace. Researchers are optimistic about expanding … … READ MORE >